All In MedTech

Device Trial Radar · NCT04984993

Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction

A Multi-centre, Randomised, Open-label, Home Use, Parallel Group, Clinical Investigation of Topically-applied MED3000 Gel and Oral Tadalafil (5 mg) Tablets for the Treatment of Erectile Dysfunction (ED) Over a 24 Week Period

Last checked: Nov 20, 2026Latest source record: Sep 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 116 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

116

Actual

Start

Sep 14, 2021

Primary completion

Jul 13, 2022

Study completion Jul 13, 2022

Sponsor

Lead sponsor
Futura Medical Developments Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Aug 2, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 22 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An open-label investigation using MED3000 gel or tadalafil (5 mg) tablets in the treatment of erectile dysfunction in patients from 22 to 70 years of age. Each patients will be expected to participate for up to 30 weeks. Eligible patients will be randomised to receive either MED3000 gel or tadalafil (5 mg) tablets in a 1:1 ratio.

Conditions

  • Erectile Dysfunction

Interventions

  • MED3000 (Male)Device

    Gel formulation

  • Tadalafil 5mg (Male)Drug

    Tablets

  • MED3000 (Female)Device

    Gel formulation

  • Tadalafil 5mg (Female)Drug

    Tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the Erectile Function (EF) Domain of the International Index of Erectile Function (IIEF) Questionnaire, in Patients Randomised to MED3000, at Week 24Time frame: Baseline and Week 24

Locations

18 sites in 4 countries. Site status is shown where the registry gives one.

  • Johns Hopkins University

    Baltimore, Maryland

  • Medical Center "Asklepii"OOD

    Dupnitsa, Bulgaria

  • ЕТ "Аssoc. Prof. Stefan Popov - Individual Practice for Specialized Outhospital medical care for Neurology and Pscyhiatry"

    Plovdiv, Bulgaria

15 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.